Osaic Holdings’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-105
Closed -$391 7767
2024
Q3
$391 Sell
105
-614
-85% -$2.93K ﹤0.01% 7050
2024
Q2
$4.03K Buy
719
+553
+333% +$2.41K ﹤0.01% 6278
2024
Q1
$869 Sell
166
-1,419
-90% -$7.79K ﹤0.01% 6711
2023
Q4
$8.29K Buy
1,585
+215
+16% +$2.12K ﹤0.01% 5924
2023
Q3
$21.6K Buy
1,370
+716
+109% +$12.9K ﹤0.01% 5512
2023
Q2
$12.7K Buy
654
+604
+1,208% +$14.3K ﹤0.01% 5838
2023
Q1
$1.42K Sell
50
-3
-6% -$89 ﹤0.01% 6851
2022
Q4
$1K Sell
53
-3
-5% -$95 ﹤0.01% 7009
2022
Q3
$1K Sell
56
-42
-43% -$1.54K ﹤0.01% 7118
2022
Q2
$4K Hold
98
﹤0.01% 6652
2022
Q1
$5K Sell
98
-230
-70% -$11K ﹤0.01% 6525
2021
Q4
$17K Sell
328
-13
-4% -$674 ﹤0.01% 5920
2021
Q3
$19K Hold
341
﹤0.01% 5831
2021
Q2
$14K Sell
341
-88
-21% -$3.63K ﹤0.01% 5884
2021
Q1
$17K Buy
429
+19
+5% +$882 ﹤0.01% 5598
2020
Q4
$20K Sell
410
-1
-0.2% -$47 ﹤0.01% 5169
2020
Q3
$15K Buy
411
+151
+58% +$6.61K ﹤0.01% 5084
2020
Q2
$12K Buy
260
+41
+19% +$2.05K ﹤0.01% 5106
2020
Q1
$11K Buy
+219
New +$11K ﹤0.01% 4967

Other funds holding EGRX

Osaic Holdings's EGRX Position: Q4 2024 in Review

Osaic Holdings sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q4 2024, closing a stake of 105 shares — an estimated $391 sold.

Osaic Holdings first reported a position in EGRX in Q1 2020 and held it in 19 quarters. The position peaked at $21.6K in Q3 2023. 9 funds tracked by Wall St. Rank hold EGRX as of Q4 2024.

  • Osaic Holdings reported no remaining Eagle Pharmaceuticals, Inc. position as of Q4 2024 after selling out during the quarter.
  • Osaic Holdings sold 105 Eagle Pharmaceuticals, Inc. shares in Q4 2024, an estimated $391.
  • Osaic Holdings first reported a position in Eagle Pharmaceuticals, Inc. in Q1 2020 and held it in 19 quarters.
  • Osaic Holdings's Eagle Pharmaceuticals, Inc. position peaked at $21.6K in Q3 2023.
  • 9 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q4 2024.

Based on Osaic Holdings's 13F filing for Q4 2024, filed 7 Feb 2025.